Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21: A Randomized Clinical Trial

IMPORTANCE: Cell-free DNA (cfDNA) tests are increasingly being offered to women in the first trimester of pregnancies at a high risk of trisomy 21 to decrease the number of required invasive fetal karyotyping procedures and their associated miscarriages. The effect of this strategy has not been eval...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:JAMA
Päätekijät: Malan, Valérie, Bussières, Laurence, Winer, Norbert, Jais, Jean-Philippe, Baptiste, Amandine, Le Lorc’h, Marc, Elie, Caroline, O’Gorman, Neil, Fries, Nicolas, Houfflin-Debarge, Véronique, Sentilhes, Loic, Vekemans, Michel, Ville, Yves, Salomon, Laurent J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Medical Association 2018
Aiheet:
Original Investigation
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583003/
https://ncbi.nlm.nih.gov/pubmed/30120476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.9396
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia